MEDVi, a telehealth platform serving more than 100,000 patients, today announced continued nationwide momentum as ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

Novo Nordisk’s new Wegovy pill hit the market this week. The Danish drug maker, best known for GLP-1 injections like Ozempic ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve adherence and boost long-term outcomes.

People who stop taking GLP-1 drugs such as Ozempic and Wegovy for weight loss are projected to regain their shed pounds ...

The retrospective study could not determine whether some patients were more likely than others to keep off the weight.

Fact checked by Nick Blackmer The first GLP-1 pill for weight loss is now available, offering a daily oral alternative to ...

When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those ...

Semaglutide is gaining recognition as a promising treatment for women facing hormonal weight loss challenges. This approach ...

A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...